SCHEMBL14424364

SCHEMBL14424364

CCC(C)S(=O)(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc3c(c2)OCCO3)CC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
MAPT P10636 6/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ALDH1A1 P00352 6/20 0.53
POLB P06746 3/20 0.53
GAA P10253 2/20 0.51
NPSR1 Q6W5P4 3/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
LMNA P02545 2/20 0.50
MAPK1 P28482 1/20 0.50
USP2 O75604 1/20 0.49
HTT P42858 1/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 2/20 0.49
TP53 P04637 1/20 0.49
HSD17B10 Q99714 1/20 0.48
CYP2C19 P33261 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10114876 1.00 KDM4E (0.58) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL10114883 0.92 KDM4E (0.56) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL14424370 0.92 KDM4E (0.56) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL14424114 0.89 KDM4E (0.62) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL10114121 0.89 KDM4E (0.62) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL10113953 0.83 NPC1 (0.61) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL14424113 0.83 NPC1 (0.61) KDM4EMAPTMEN1KMT2AALDH1A1
SCHEMBL13565934 0.81 CNR2 (0.42) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL17090262 0.81 CNR2 (0.42) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL13203862 0.81 KDM4E (0.62) KDM4EMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R KDM4E 1668/4885MAPT 3602/4885MEN1 2876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.